Home
News
Create
Screeners
Insights
Fabtech Technologies
141.
50
-8.39
(-5.60%)
Market Cap
₹628.98 Cr
PE Ratio
21.53
Industry
Healthcare
Buy
Sell
Company Performance:
1D
-5.60%
1M
-14.12%
6M
-22.42%
1Y
-22.42%
5Y
-22.42%
View Company Insights
Latest news about Fabtech Technologies
Fabtech Technologies Clarifies Share Price Movement as Market Driven
2 days ago
Fabtech Technologies Limited responded to stock exchange clarification requests regarding share price movements on March 11, 2026. The company confirmed no pending price-sensitive information exists and attributed price movements to market forces. Executive Director Hemant Mohan Anavkar assured continued compliance with SEBI disclosure requirements.
Fabtech Technologies Submits Investor Presentation for CVOCA Investocraft 2026
Feb 28, 2026
Fabtech Technologies Secures USD 7.05 Million International Contract from West Africa
Feb 14, 2026
Fabtech Technologies Q3FY26 Earnings Call Reveals Revenue Timing Issues, Strong Order Book
Feb 14, 2026
Fabtech Technologies Makes Q3FY26 Earnings Call Recording Available Online
Feb 11, 2026
More news about Fabtech Technologies
02
Feb 26
Fabtech Technologies Reports Q3FY26 Results with ₹567.79L Loss and Risk Committee Dissolution
Fabtech Technologies announced Q3FY26 results showing consolidated net loss of ₹567.79 lakhs compared to ₹2,045.74 lakhs profit in Q3FY25, with revenue declining 39.84% year-over-year. The Board dissolved the Risk Management Committee and utilized ₹2,350.25 lakhs of IPO proceeds during the quarter.
19
Dec 25
Fabtech Technologies Cleanrooms Secures ₹330 Million Order
Fabtech Technologies Cleanrooms has won a significant order worth ₹330 million in the cleanroom solutions sector. This large-scale contract demonstrates the company's capabilities in securing substantial projects and is expected to positively impact its revenue pipeline. The order reinforces Fabtech's competitive position and technical expertise in the specialized cleanroom technology market.
18
Nov 25
Fabtech Technologies Clarifies Corporate Identity: Separate from Fabtech Technologies Cleanrooms Ltd
Fabtech Technologies Limited (FTL) has issued a statement to address market confusion, emphasizing its separate identity from Fabtech Technologies Cleanrooms Limited (FTCL). FTL and FTCL are independent, listed companies with distinct management teams and business strategies. FTL focuses on international turnkey life sciences infrastructure across 62 countries, while FTCL primarily serves India's cleanroom infrastructure needs. The companies have different stock listings, symbols, and ISINs. This clarification aims to prevent investor confusion and ensure accurate market representation.
14
Nov 25
Fabtech Technologies Reports 109.9% Revenue Growth in H1 FY26, Expands Global Footprint
Fabtech Technologies Limited, a global turnkey engineering solutions provider for pharmaceutical sectors, reported robust H1 FY2026 results. Total income reached INR 19,322.80 lakhs, up 109.9% year-on-year. Net profit increased by 101.6% to INR 2,198.02 lakhs. EBITDA improved to INR 2,839.99 lakhs with margins at 14.7%. The company maintains a strong order book of INR 90,441.87 lakhs as of July 31, 2025, with 7-9% growth from July to September 2025. Operating in 22 countries, Fabtech focuses on MENA, GCC, and ECO Zone regions, offering end-to-end turnkey solutions for pharmaceutical manufacturing. The company's asset-light model and in-house manufacturing capabilities enhance execution agility and cost efficiency.
06
Nov 25
Fabtech Technologies Reports Robust Q2 FY26 Results with 109.91% Revenue Growth, Targets Expansion in Bio-Pharma Sector
Fabtech Technologies Limited announced impressive Q2 FY26 results, with total income rising 109.91% YoY to ₹12,427.61 crores. Net profit surged 449.12% to ₹2,810.61 crores, while EBITDA margin expanded to 27.06%. The company's current order book stands at ₹90,441.87 lakhs, with operations across 62 countries. Fabtech is targeting growth in bio-pharma equipment, modular facilities, and engineering turnkey projects, leveraging its expertise in pharmaceutical and healthcare engineering solutions.
05
Nov 25
Fabtech Technologies Reports Net Loss in Q1 FY26, Strong Rebound in Q2
Fabtech Technologies Limited reported a significant turnaround in Q2 FY26, with revenue increasing 78.6% to ₹12,148.07 lakhs and net profit reaching ₹2,810.61 lakhs, compared to a loss in Q1. The company completed its IPO and listed on NSE and BSE in October 2025. Additionally, Fabtech secured a ₹52 crore contract for a veterinary formulations facility in North Africa, boosting its order book to ₹983.05 crore. An earnings call is scheduled for November 10, 2025, to discuss Q1 and Q2 FY26 results.
03
Nov 25
Fabtech Technologies Secures ₹52 Crore Contract for Veterinary Facility in North Africa
Fabtech Technologies Limited (FTL) has won a ₹52 crore contract to build a veterinary medicines manufacturing facility in North Africa's Maghreb region. The project includes complete design, engineering, cleanroom systems, utilities, and process equipment. This addition boosts FTL's cumulative order book to ₹983.05 crore. The Maghreb veterinary formulation market is projected to reach USD 500-700 million by 2030, driven by increasing demand for animal health products and food security goals. This contract marks FTL's strategic expansion in both human and animal healthcare sectors, leveraging its in-house capabilities to capitalize on growing markets.
Fabtech Technologies
141.
50
-
8.
39
(-
5.
60
%)
1 Year Returns:
-22.42%
Industry Peers
Poly Medicure
1,260.20
(-
3.
97
%)
Tarsons Products
192.78
(-
0.
76
%)
Laxmi Dental
178.51
(-
2.
81
%)
Osel Devices
463.15
(-
4.
90
%)
Vasa Denticity
390.45
(-
0.
95
%)
Fabtech Technologies
141.50
(-
5.
60
%)
Prevest Denpro
408.10
(+
1.
90
%)
Aprameya Engineering
219.00
(-
4.
78
%)
Hemant Surgical Industries
266.00
(-
2.
21
%)
Nureca
257.45
(-
3.
90
%)
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/ Block Deals
Stock Rental via SLBM
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation
IPO